Global Proteomics Market Report By Product (Instruments, Reagents, Services), By Service and Software (Core Proteomics Services, Bioinformatics Software & Services), By End User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Laboratories, Other) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2020-2027

ID:VMR11214795
April 2021
Report Formats:

Global Proteomics Market Overview
The key driver impacting the proteomics market is the growing occurrence of target diseases such as cancer, diabetes, and cardiovascular. For instance, The National Center for Biotechnology Information (NCBI) report presents that almost one in three adults suffers from multiple chronic conditions (MCCs). The WHO report shows that chronic disease accounts for 60% of the worldwide disease burden in 2020. Globally cancer is responsible for the second most leading cause of death, and it accounted for 9.6 million deaths in 2018. Similarly, diabetes is also one of the most prevalent diseases globally. As per the International Diabetic Federation (IDF), In 2019, over 463 million adults (20-79 years) were living with diabetes, and it is likely to reach 700 million by 2045. Moreover, the growing demand for advanced diagnostics in targeted disease treatment contributes to Proteomics's market growth in the coming years.

According to Value Market Research, the global proteomics market size was valued at around USD 24500 million in 2020 and is estimated to grow at a CAGR of about 15% during the forecast period 2021 to 2027.

 
The increasing R&D expenditure and government funding for proteomics and drug discovery are estimated to augment proteomics in the forecast period. For instance, In 2019, The European Union has awarded 10 million euros to a consortium of 18 European research groups focusing on proteomics research. Similarly, the NIH/NCI 420 - Single-Cell “Unbiased Discovery” Proteomic Technologies funding was declared on July 29th, 2020, will grant 3 to 5 qualified recipients with the opportunity to expand proteomic technologies for untargeted proteome discovery in a usual single-cell. Also, there are considerable funding in the field of drug discovery.  Also, there are significant fundings in the area of drug discovery. For example, NIH funding adds to published research linked with every one of the 210 new drugs allowed by the Food and Drug Administration between 2010–2016. The grant funding in total is more than $100 billion for this research. However, the high cost of instruments may hamper the market in the long run. Also, the presence of an ambiguous regulatory framework negatively impacts the market. The current industry trends, such as the increasing popularity of personalized medicines, the rising prominence of nanoproteomics, and technological advancements associated with proteomics components, are expected to offer new lucrative market opportunities for the key players.
 
The Proteomics market is vast, with many local and global players. The Proteomics market is extensive, with many regional and international players. The important market leaders follow numerous strategies to improve their market position, such as acquisitions, extending product portfolio, contracts, amalgamation, contracts, acquisitions, product upgrades to enlarge their market share across the globe. The significant players studied in the report include Roche Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Agilent Technologies Inc., LI-COR, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., HORIBA, Ltd., Bruker Corporation, Bio-Rad Laboratories, Inc., General Electric (GE), and Waters Corporation and GE Healthcare.

Global Proteomics Market Share
 
 

Know more about this report: Download free sample

In this research report, the Proteomics market is segmented by product, service and software, end-user, and region.
 
Analysis by Product:
 
By product, the report is categorized into reagents, instruments, and services. The Immunoassay
reagents segment dominates the type segment with over 20% share in 2020. It is due to the widespread research in academic institutes coupled with a high frequency of usage of reagents, kits, chemicals, and strips for the analysis of various biological samples. The easy availability of a broad range of reagents and the requirement for specific, reliable, and rapid detection of diseases at the early stages add growth to the market. Moreover, the growing utilization of immunoassays to enumerate molecules of a biological notice on the basis of specificity and selectivity of antibody reagents generated contribute to the massive demand for reagents segment in the forecast period.
 
Analysis by Service and Software:
 
By service and software, the report is categorized into core proteomics services and bioinformatics software & services. The core proteomics services segment dominates the services segment with over 55% share in 2020. It is due to the rising demand as it utilized current and innovative proteomics techniques, the core advances scientific knowledge of disease biogenesis which contributes to improved patient care. Moreover, the increasing importance of such studies for targeted diagnosis and treatment leads to rising demand contributing to Core Proteomics Services segment growth in the forecast period.
                           
Analysis by End-User:

By end-user, the report is categorized into pharmaceutical companies, hospitals, clinical laboratories, academic research laboratories, and other end users. The pharmaceutical companies segment dominates the services segment with over 30% share in 2020. It is due to the rising research and development to develop new drugs worldwide and the increasing prevalence of chronic diseases among the population that leads to more research on developing effective drugs. Moreover, the rising outsourcing of research activities to diverse pharmaceutical companies with in-house CRO services contributing to high market demand from pharmaceutical companies segment growth in the forecast period. 
 
Analysis by Region:

In the regional outlook of the global Proteomics market, the North America region dominates globally with a 35% market share in the forecast period. It is due to the increase in popularity and adoption of personalized medicines with the presence of sophisticated healthcare infrastructure, a large base of the target population, and the presence of key industry players in this region. Moreover, favorable government funding & initiatives to develop novel therapeutics contributes to tremendous market growth across North America.
 
Market Segmentation covered in the Report:
By Product

  • Instruments
  • Reagents (Microarray, Spectrometry, X-ray crystallography, Chromatography, Electrophoresis, Immunoassay, Protein Fractionation Reagent)
  • Services

By Service and Software

  • Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomic Services, Protein Purification Services, Protein Sequencing Services, Custom Assay Services)
  • Bioinformatics Software & Services (Bioinformatics Software, Bioinformatics Tools, Bioinformatics Databases)

By End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Academic Research Laboratories
  • Other

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 
METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . PROTEOMICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product
           3.7.2 By Service and Software
           3.7.3 By End User
           3.7.4 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL PROTEOMICS MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Instruments Market by Regions
       6.5 Reagents Market by Regions
       6.6 Services Market by Regions
 
7 . GLOBAL PROTEOMICS MARKET ANALYSIS BY SERVICE AND SOFTWARE
       7.1 Overview by Service and Software
       7.2 Historical and Forecast Data
       7.3 Analysis by Service and Software
       7.4 Core Proteomics Services Market by Regions
       7.5 Bioinformatics Software & Services Market by Regions
 
8 . GLOBAL PROTEOMICS MARKET ANALYSIS BY END USER
       8.1 Overview by End User
       8.2 Historical and Forecast Data
       8.3 Analysis by End User
       8.4 Hospitals Market by Regions
       8.5 Clinical Laboratories Market by Regions
       8.6 Pharmaceutical Companies Market by Regions
       8.7 Academic Research Laboratories Market by Regions
       8.8 Other Market by Regions
 
9 . GLOBAL PROTEOMICS MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview, Historic and Forecast Data
           9.3.2. North America By Segment
           9.3.3. North America By Country
           9.3.4. United State
           9.3.5. Canada
           9.3.6. Mexico
       9.4. Europe
           9.4.1. Overview, Historic and Forecast Data
           9.4.2. Europe by Segment
           9.4.3. Europe by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7. Italy
           9.4.8. Russia
           9.4.9. Rest Of Europe
       9.5. Asia Pacific
           9.5.1. Overview, Historic and Forecast Data
           9.5.2. Asia Pacific by Segment
           9.5.3. Asia Pacific by Country
           9.5.4. China
           9.5.5. India
           9.5.6. Japan
           9.5.7. South Korea
           9.5.8. Australia
           9.5.9. Rest Of Asia Pacific
       9.6. Latin America
           9.6.1. Overview, Historic and Forecast Data
           9.6.2. Latin America by Segment
           9.6.3. Latin America by Country
           9.6.4. Brazil
           9.6.5. Argentina
           9.6.6. Peru
           9.6.7. Chile
           9.6.8. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview, Historic and Forecast Data
           9.7.2. Middle East & Africa by Segment
           9.7.3. Middle East & Africa by Country
           9.7.4. Saudi Arabia
           9.7.5. UAE
           9.7.6. Israel
           9.7.7. South Africa
           9.7.8. Rest Of Middle East And Africa
 
10 . COMPETITIVE LANDSCAPE OF THE PROTEOMICS COMPANIES
       10.1. Proteomics Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF PROTEOMICS INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Roche Diagnostics
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Thermo Fisher Scientific, Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Bio-Rad Laboratories
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Agilent Technologies Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. LI-COR, Inc.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Danaher Corporation
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Thermo Fisher Scientific, Inc.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. PerkinElmer, Inc.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. HORIBA, Ltd.
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Bruker Corporation
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Bio-Rad Laboratories, Inc.
           11.13.1. Company Overview
           11.13.2. Financials
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. General Electric (GE)
           11.14.1. Company Overview
           11.14.2. Financials
           11.14.3. Products
           11.14.4. Recent Developments
       11.15. Waters Corporation and GE Healthcare
           11.15.1. Company Overview
           11.15.2. Financials
           11.15.3. Products
           11.15.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES
 

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product  (USD MN)
  • Instruments Market by Geography (USD MN)
  • Reagents Market by Geography (USD MN)
  • Services Market by Geography (USD MN)
  • Analysis Market by Service and Software (USD MN)
  • Core Proteomics Services Market by Geography (USD MN)
  • Bioinformatics Software & Services Market by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Clinical Laboratories Market by Geography (USD MN)
  • Pharmaceutical Companies Market by Geography (USD MN)
  • Academic Research Laboratories Market by Geography (USD MN)
  • Other Market by Geography (USD MN)
  • Global Proteomics Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

 
 LIST OF FIGURES
 

  • Research Scope of Proteomics Report
  • Market Research Process
  • Market Research Methodology
  • Global Proteomics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Service and Software
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product  (USD MN)
  • Instruments Market by Geography (USD MN)
  • Reagents Market by Geography (USD MN)
  • Services Market by Geography (USD MN)
  • Global Market Analysis by Service and Software (USD MN)
  • Core Proteomics Services Market by Geography (USD MN)
  • Bioinformatics Software & Services Market by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Clinical Laboratories Market by Geography (USD MN)
  • Pharmaceutical Companies Market by Geography (USD MN)
  • Academic Research Laboratories Market by Geography (USD MN)
  • Other Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020

 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials